MICAL1 (molecule interacting with CasL 1) protects oligodendrocyte cells from oxidative injury through regulating apoptosis, autophagy in spinal cord injury

Chang Xu,Liang Mao,He Tian,Sen Lin,Xiaoguang Zhao,Jiaquan Lin,Daoyong Li,Xian Li,Xifan Mei
DOI: https://doi.org/10.1016/j.neulet.2021.135712
IF: 3.197
2021-04-01
Neuroscience Letters
Abstract:<p>Molecule's mechanism of action interacting with CasL 1 (MICAL1) in spinal cord injury (SCI) is unclear. This study aimed to detect the function of MICAL1 in SCI. Western blot was used to analyze the change of MICAL1 in vivo. Immunofluorescence staining was used to detect the location of MICAL1 expression. Oligodendrocyte cells were treated with H<sub>2</sub>O<sub>2</sub> to induce oxidative injury. Subsequently, siRNA transfection was performed to decrease MICAL1 expression in oligodendrocyte cells. Then, the effects of MICAL1 on oxidative stress, apoptosis, and autophagy were assessed. We found that silencing of MICAL1 could significantly reduce the levels of the nuclear factor erythroid 2-related factor 2 (Nrf2), increase the expression of pro-apoptotic factors (Bax and C-caspase 3), decrease the levels of anti-apoptotic factor (Bcl-2) and pro-autophagy factors ( Beclin1 and LC3B). Therefore, MICAL1 is a potential target gene for SCI clinical therapy.</p>
neurosciences
What problem does this paper attempt to address?